India has reaffirmed its commitment to supporting Sri Lanka in the battle against one of the world's most persistent infectious diseases, as New Delhi agreed to continue providing technical and other forms of assistance to help the island nation strengthen its tuberculosis (TB) control efforts. The announcement marks a significant step forward in the health diplomacy between the two neighboring countries and underscores India's growing role as a regional partner in public health initiatives across South Asia.
India's Commitment to Regional Health Diplomacy
The decision to extend technical support to Sri Lanka reflects India's broader foreign policy approach of fostering goodwill and cooperation among its regional neighbors through practical, people-centered initiatives. Health cooperation has increasingly become a cornerstone of India's diplomatic engagements across South Asia, and the renewed commitment to Sri Lanka's TB control program is a clear demonstration of this strategy in action.
India, which has itself undertaken one of the world's most ambitious TB elimination programs under its National TB Elimination Programme (NTEP), is well-positioned to share its expertise, resources, and technical knowledge with Sri Lanka. With a target to eliminate TB by 2025 — five years ahead of the global Sustainable Development Goal deadline — India has accumulated considerable experience in managing TB surveillance, patient care, drug supply chains, and community outreach programs that could prove invaluable to Sri Lanka's own efforts.
The Tuberculosis Challenge in Sri Lanka
Tuberculosis remains a significant public health concern in Sri Lanka, despite the country making notable progress in reducing its TB burden over recent decades. The World Health Organization (WHO) classifies TB as one of the top infectious disease killers globally, and while Sri Lanka is not among the highest-burden countries, the disease continues to pose challenges, particularly in urban areas and among vulnerable populations.
Sri Lanka's National Programme for Tuberculosis Control and Chest Diseases has been working steadily to improve detection rates, ensure treatment completion, and reduce transmission across the country. However, challenges such as drug-resistant TB, stigma surrounding the disease, and gaps in healthcare access in certain regions continue to hinder progress. External technical support, particularly from a country with the scale and experience of India, can play a meaningful role in addressing these persistent gaps.
What Technical Support Will Entail
The technical assistance that India has agreed to extend is expected to cover multiple dimensions of TB control. This includes sharing best practices in diagnostic technologies, particularly in the areas of rapid molecular testing and advanced laboratory capacity building. India's experience in deploying tools such as the GeneXpert diagnostic system across vast and diverse geographies could help Sri Lanka improve its early detection capabilities significantly.
Additionally, India is expected to support Sri Lanka in strengthening its drug management systems to prevent shortages and ensure consistent supply of first-line and second-line anti-TB medications. Training programs for healthcare workers, including doctors, nurses, and community health volunteers, are also anticipated to form a key part of the cooperation framework. Such capacity-building efforts are critical to sustaining long-term improvements in TB outcomes.
Digital health solutions, which India has pioneered through platforms like Ni-kshay — a web-based patient management system for TB — may also be shared with Sri Lanka to improve patient tracking, treatment adherence monitoring, and data collection for better program management.
Strengthening Bilateral Ties Through Health Cooperation
The agreement to extend TB-related support comes at a time when India and Sri Lanka are actively working to deepen their bilateral relationship across multiple sectors. Health cooperation has emerged as a particularly meaningful area of engagement, given the direct impact it has on the lives of ordinary citizens in both countries.
India's assistance to Sri Lanka during the island nation's economic crisis in recent years demonstrated the strength of the partnership between the two countries. Extending support in the health sector, particularly in combating a disease like tuberculosis that disproportionately affects economically vulnerable populations, further cements this relationship on humanitarian grounds.
Health experts and policymakers in Sri Lanka have welcomed the announcement, expressing hope that the renewed collaboration will accelerate the country's progress toward TB elimination. The partnership is also seen as complementary to Sri Lanka's ongoing work with international organizations such as the WHO and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Looking Ahead
As both countries move forward with formalizing the details of this technical cooperation, the focus will be on creating sustainable systems that can outlast any single program or funding cycle. Building local capacity, investing in research, and fostering community awareness are all essential components of a durable TB control strategy.
India's decision to stand by Sri Lanka in this fight is not merely a diplomatic gesture — it is a practical investment in the health and stability of the region. With coordinated effort, shared knowledge, and sustained commitment from both sides, the goal of a tuberculosis-free South Asia moves one step closer to becoming a reality.